Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-24 @ 11:59 AM
NCT ID:
NCT01082861
Eligibility Criteria:
Inclusion Criteria:
1. Female pre-adolescents born in 1998, eligible for HPV vaccination in 2011.
2. Able to fulfill all study requirements.
Exclusion Criteria:
1. Previous vaccination with any licensed or experimental HPV or HBV vaccine.
2. Contraindication for vaccination with Cervarix®.
3. Contraindication for vaccination with Engerix-B®.
4. Use of investigational vaccine or medication within 30 days before study
5. History of severe adverse reaction associated with a vaccine or vaccine component.
6. Heart disease
7. Liver disease
8. Spleen removal
9. Asthma
10. Immune deficiency or suppression
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
11 Years
Maximum Age:
12 Years
Study:
NCT01082861
Study Brief:
Protocol Section:
NCT01082861